Please login to the form below

Not currently logged in
Email:
Password:

Teva Generics Europe appoints president and CEO

Promotes former UK general manager Richard Daniell

Teva Richard DaniellTeva has appointed Richard Daniell as president and chief executive officer of Teva Generics Europe, following Dipankar Bhattacharjee's promotion to a global role.

Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Prior to this, he was chief operating officer, growth markets region and served as general manager of Teva UK from 2011 to 2015.

Bhattacharjee, president and chief executive of global generic medicines said: “Richard has shown visionary leadership, has built high-performing teams across the company and has an impressive record in driving commercial success.”

21st December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics